A Phase II Study of PX-866 in Patients with Glioblastoma Multiforme at Time of First Relapse or Progression
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Sonolisib (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 15 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 07 Feb 2014 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 21 May 2013 Results will be presented at the ASCO 2013 meeting, according to the Oncothyreon Q1 2013 financial report.